Precision medicine in Hepatitis B: the diagnostic power of biomarkers

April 7, 2025 Bullet Article
Seng Gee LimSeng Gee Lim
Conferences Infectious Diseases Liver disease & HCC Singapore
Share this:
Copy link
hepatitis b treatment​

Prof Seng Gee Lim, Director of Hepatology, Department of Gastroenterology and Hepatology at Singapore’s National University Health System, promotes the use of biomarkers in diagnostics to manage and allow tailored, personalised treatment for patients with hepatitis B, contributing to the overall improvement of patient outcome.

Share this:
Copy link

More on same topic

Select a related post from the options below.

Addressing the underdiagnosis of Hepatitis E in Vietnam with Dr Nguyen Nguyen Huyen

Taiwan’s Hepatitis C elimination journey: lessons in diagnostics-driven prevention

Recommended topics

SequencingRED 2020Rare Diseases
Next Read
Management
• Articles
Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
Management
• Articles
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
Operations
• Articles
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Operations
• Articles
Chasing the Invisible and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top